This Teachable Moment uses the case of a woman in her 30s undergoing chemotherapy for stage 2A breast cancer who was hospitalized
for febrile neutropenia to illustrate the need to avoid overtreatment for low - risk patients with this common oncological complication.
Not exact matches
We can conclude that primary or secondary prophylaxis of
febrile neutropenia with G - CSF is justified, but patients at higher risk
for thrombocytopenia should be treated with caution.»
Knowing local spectrum and sensitivity
for bacterial isolates causing
febrile neutropenia is important as starting an appropriate empirical antibiotic therapy is considered a medical emergency in these high - risk patients.